Both in Pharmaceuticals
Grace Therapeutics vs Veru
Over the past year GRCE returned −37.0% and VERU returned −37.8%; their daily moves had a correlation of 0.07.
GRCE −37.0% VERU −37.8%Growth of $1, one year, split-adjusted
| Metric | GRCE | VERU |
|---|---|---|
| Price | $2.01 | $2.27 |
| Market cap | $42.3M | $38.7M |
| Today | +7.49% | −0.44% |
| 1 month | −4.7% | −11.3% |
| 6 months | −4.3% | +1.3% |
| Year to date | −41.9% | +6.1% |
| 1 year | −36.2% | −40.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $13.8M | $25.8M |
| Dividend yield | — | — |
| Volatility (60d) | 41.0% | 63.5% |
| Short % of float | 11.2% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).